Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Metronidazole Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Metronidazole Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Pharma & Healthcare
Published Date: 2025-09-11
Pages: 168 Pages
Report ld: 5043913
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Metronidazole Market Size(US$)
CAGR 2025-2031
-0.46%
Market Size,2031
USD 108
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 111 million
Market Forecast in 2031(Value)
US$ 108 million
CAGR
-0.46%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Metronidazole market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Hongyuan Pharmaceutical
- Yinhe Aarti Pharmaceutical
- Saikang Pharmaceutical
- Zhongan Pharmaceutical
- Wuyao Pharmaceutical
- Yichang Changjiang Pharmaceutical
- Tongji Pharmaceutical
- Hongda Pharmaceutical
- Topsun Pharmaceutical
- Unichem Laboratories
- CordenPharma Farchemia
- API Polpharma
- Manav Drugs
- Aarey Drugs & Pharmaceuticals
- Aarti Drugs
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Glyoxal Process
- Ethidene Diamine Process
- Others
Segment by Application
- Metronidazole Tablets
- Metronidazole Capsule
- Metronidazole Injection
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Metronidazole study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Metronidazole: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Metronidazole Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Glyoxal Process
1.2.3 Ethidene Diamine Process
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Metronidazole Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsule
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Metronidazole Revenue Estimates and Forecasts 2020-2031
2.2 Global Metronidazole Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Metronidazole Sales Estimates and Forecasts 2020-2031
2.4 Global Metronidazole Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Metronidazole Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Metronidazole Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Glyoxal Process Market Size by Manufacturers
3.5.2 Ethidene Diamine Process Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Metronidazole Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Metronidazole Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Metronidazole Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Metronidazole Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Metronidazole Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Metronidazole Sales and Revenue by Type (2020-2031)
6.4 North America Metronidazole Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Metronidazole Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Metronidazole Sales and Revenue by Type (2020-2031)
7.4 Europe Metronidazole Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Metronidazole Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Metronidazole Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Metronidazole Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Metronidazole Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Metronidazole Sales and Revenue by Type (2020-2031)
9.4 Central and South America Metronidazole Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Metronidazole Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Metronidazole Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Metronidazole Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Metronidazole Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Hongyuan Pharmaceutical
11.1.1 Hongyuan Pharmaceutical Corporation Information
11.1.2 Hongyuan Pharmaceutical Business Overview
11.1.3 Hongyuan Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.1.4 Hongyuan Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Hongyuan Pharmaceutical Metronidazole Sales by Product in 2024
11.1.6 Hongyuan Pharmaceutical Metronidazole Sales by Application in 2024
11.1.7 Hongyuan Pharmaceutical Metronidazole Sales by Geographic Area in 2024
11.1.8 Hongyuan Pharmaceutical Metronidazole SWOT Analysis
11.1.9 Hongyuan Pharmaceutical Recent Developments
11.2 Yinhe Aarti Pharmaceutical
11.2.1 Yinhe Aarti Pharmaceutical Corporation Information
11.2.2 Yinhe Aarti Pharmaceutical Business Overview
11.2.3 Yinhe Aarti Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.2.4 Yinhe Aarti Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Yinhe Aarti Pharmaceutical Metronidazole Sales by Product in 2024
11.2.6 Yinhe Aarti Pharmaceutical Metronidazole Sales by Application in 2024
11.2.7 Yinhe Aarti Pharmaceutical Metronidazole Sales by Geographic Area in 2024
11.2.8 Yinhe Aarti Pharmaceutical Metronidazole SWOT Analysis
11.2.9 Yinhe Aarti Pharmaceutical Recent Developments
11.3 Saikang Pharmaceutical
11.3.1 Saikang Pharmaceutical Corporation Information
11.3.2 Saikang Pharmaceutical Business Overview
11.3.3 Saikang Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.3.4 Saikang Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Saikang Pharmaceutical Metronidazole Sales by Product in 2024
11.3.6 Saikang Pharmaceutical Metronidazole Sales by Application in 2024
11.3.7 Saikang Pharmaceutical Metronidazole Sales by Geographic Area in 2024
11.3.8 Saikang Pharmaceutical Metronidazole SWOT Analysis
11.3.9 Saikang Pharmaceutical Recent Developments
11.4 Zhongan Pharmaceutical
11.4.1 Zhongan Pharmaceutical Corporation Information
11.4.2 Zhongan Pharmaceutical Business Overview
11.4.3 Zhongan Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.4.4 Zhongan Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Zhongan Pharmaceutical Metronidazole Sales by Product in 2024
11.4.6 Zhongan Pharmaceutical Metronidazole Sales by Application in 2024
11.4.7 Zhongan Pharmaceutical Metronidazole Sales by Geographic Area in 2024
11.4.8 Zhongan Pharmaceutical Metronidazole SWOT Analysis
11.4.9 Zhongan Pharmaceutical Recent Developments
11.5 Wuyao Pharmaceutical
11.5.1 Wuyao Pharmaceutical Corporation Information
11.5.2 Wuyao Pharmaceutical Business Overview
11.5.3 Wuyao Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.5.4 Wuyao Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Wuyao Pharmaceutical Metronidazole Sales by Product in 2024
11.5.6 Wuyao Pharmaceutical Metronidazole Sales by Application in 2024
11.5.7 Wuyao Pharmaceutical Metronidazole Sales by Geographic Area in 2024
11.5.8 Wuyao Pharmaceutical Metronidazole SWOT Analysis
11.5.9 Wuyao Pharmaceutical Recent Developments
11.6 Yichang Changjiang Pharmaceutical
11.6.1 Yichang Changjiang Pharmaceutical Corporation Information
11.6.2 Yichang Changjiang Pharmaceutical Business Overview
11.6.3 Yichang Changjiang Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.6.4 Yichang Changjiang Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Yichang Changjiang Pharmaceutical Recent Developments
11.7 Tongji Pharmaceutical
11.7.1 Tongji Pharmaceutical Corporation Information
11.7.2 Tongji Pharmaceutical Business Overview
11.7.3 Tongji Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.7.4 Tongji Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Tongji Pharmaceutical Recent Developments
11.8 Hongda Pharmaceutical
11.8.1 Hongda Pharmaceutical Corporation Information
11.8.2 Hongda Pharmaceutical Business Overview
11.8.3 Hongda Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.8.4 Hongda Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hongda Pharmaceutical Recent Developments
11.9 Topsun Pharmaceutical
11.9.1 Topsun Pharmaceutical Corporation Information
11.9.2 Topsun Pharmaceutical Business Overview
11.9.3 Topsun Pharmaceutical Metronidazole Product Models, Descriptions and Specifications
11.9.4 Topsun Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Topsun Pharmaceutical Recent Developments
11.10 Unichem Laboratories
11.10.1 Unichem Laboratories Corporation Information
11.10.2 Unichem Laboratories Business Overview
11.10.3 Unichem Laboratories Metronidazole Product Models, Descriptions and Specifications
11.10.4 Unichem Laboratories Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Unichem Laboratories Recent Developments
11.11 CordenPharma Farchemia
11.11.1 CordenPharma Farchemia Corporation Information
11.11.2 CordenPharma Farchemia Business Overview
11.11.3 CordenPharma Farchemia Metronidazole Product Models, Descriptions and Specifications
11.11.4 CordenPharma Farchemia Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 CordenPharma Farchemia Recent Developments
11.12 API Polpharma
11.12.1 API Polpharma Corporation Information
11.12.2 API Polpharma Business Overview
11.12.3 API Polpharma Metronidazole Product Models, Descriptions and Specifications
11.12.4 API Polpharma Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 API Polpharma Recent Developments
11.13 Manav Drugs
11.13.1 Manav Drugs Corporation Information
11.13.2 Manav Drugs Business Overview
11.13.3 Manav Drugs Metronidazole Product Models, Descriptions and Specifications
11.13.4 Manav Drugs Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Manav Drugs Recent Developments
11.14 Aarey Drugs & Pharmaceuticals
11.14.1 Aarey Drugs & Pharmaceuticals Corporation Information
11.14.2 Aarey Drugs & Pharmaceuticals Business Overview
11.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Product Models, Descriptions and Specifications
11.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Aarey Drugs & Pharmaceuticals Recent Developments
11.15 Aarti Drugs
11.15.1 Aarti Drugs Corporation Information
11.15.2 Aarti Drugs Business Overview
11.15.3 Aarti Drugs Metronidazole Product Models, Descriptions and Specifications
11.15.4 Aarti Drugs Metronidazole Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Aarti Drugs Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Metronidazole Industry Chain
12.2 Metronidazole Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Metronidazole Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Metronidazole Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Metronidazole Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Metronidazole Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Metronidazole Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Metronidazole Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Metronidazole Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Metronidazole Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Metronidazole Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Metronidazole Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Metronidazole Sales by Region (2020-2025) & (MT)
Table 8. Global Metronidazole Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Metronidazole Sales by Manufacturers (2020-2025) & (MT)
Table 11. Global Metronidazole Sales Share by Manufacturers (2020-2025)
Table 12. Global Metronidazole Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Metronidazole Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Metronidazole by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metronidazole as of 2024)
Table 16. Global Metronidazole Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Metronidazole Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Kg)
Table 18. Key Manufacturers Metronidazole Manufacturing Base and Headquarters
Table 19. Global Metronidazole Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Metronidazole Sales by Type (2020-2025) & (MT)
Table 23. Global Metronidazole Sales by Type (2026-2031) & (MT)
Table 24. Global Metronidazole Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Metronidazole Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Metronidazole ASP by Type (2020-2031) & (USD/Kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Metronidazole Sales by Application (2020-2025) & (MT)
Table 29. Global Metronidazole Sales by Application (2026-2031) & (MT)
Table 30. Metronidazole High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Metronidazole Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Metronidazole Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Metronidazole ASP by Application (2020-2031) & (USD/Kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Metronidazole Growth Accelerators and Market Barriers
Table 37. North America Metronidazole Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Metronidazole Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Metronidazole Growth Accelerators and Market Barriers
Table 40. Europe Metronidazole Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Metronidazole Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Metronidazole Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Metronidazole Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Metronidazole Growth Accelerators and Market Barriers
Table 45. Southeast Asia Metronidazole Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Metronidazole Investment Opportunities and Key Challenges
Table 47. Central and South America Metronidazole Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Metronidazole Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Metronidazole Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Hongyuan Pharmaceutical Corporation Information
Table 51. Hongyuan Pharmaceutical Description and Major Businesses
Table 52. Hongyuan Pharmaceutical Product Models, Descriptions and Specifications
Table 53. Hongyuan Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 54. Hongyuan Pharmaceutical Sales Value Proportion by Product in 2024
Table 55. Hongyuan Pharmaceutical Sales Value Proportion by Application in 2024
Table 56. Hongyuan Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 57. Hongyuan Pharmaceutical Metronidazole SWOT Analysis
Table 58. Hongyuan Pharmaceutical Recent Developments
Table 59. Yinhe Aarti Pharmaceutical Corporation Information
Table 60. Yinhe Aarti Pharmaceutical Description and Major Businesses
Table 61. Yinhe Aarti Pharmaceutical Product Models, Descriptions and Specifications
Table 62. Yinhe Aarti Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 63. Yinhe Aarti Pharmaceutical Sales Value Proportion by Product in 2024
Table 64. Yinhe Aarti Pharmaceutical Sales Value Proportion by Application in 2024
Table 65. Yinhe Aarti Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 66. Yinhe Aarti Pharmaceutical Metronidazole SWOT Analysis
Table 67. Yinhe Aarti Pharmaceutical Recent Developments
Table 68. Saikang Pharmaceutical Corporation Information
Table 69. Saikang Pharmaceutical Description and Major Businesses
Table 70. Saikang Pharmaceutical Product Models, Descriptions and Specifications
Table 71. Saikang Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 72. Saikang Pharmaceutical Sales Value Proportion by Product in 2024
Table 73. Saikang Pharmaceutical Sales Value Proportion by Application in 2024
Table 74. Saikang Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 75. Saikang Pharmaceutical Metronidazole SWOT Analysis
Table 76. Saikang Pharmaceutical Recent Developments
Table 77. Zhongan Pharmaceutical Corporation Information
Table 78. Zhongan Pharmaceutical Description and Major Businesses
Table 79. Zhongan Pharmaceutical Product Models, Descriptions and Specifications
Table 80. Zhongan Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. Zhongan Pharmaceutical Sales Value Proportion by Product in 2024
Table 82. Zhongan Pharmaceutical Sales Value Proportion by Application in 2024
Table 83. Zhongan Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 84. Zhongan Pharmaceutical Metronidazole SWOT Analysis
Table 85. Zhongan Pharmaceutical Recent Developments
Table 86. Wuyao Pharmaceutical Corporation Information
Table 87. Wuyao Pharmaceutical Description and Major Businesses
Table 88. Wuyao Pharmaceutical Product Models, Descriptions and Specifications
Table 89. Wuyao Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Wuyao Pharmaceutical Sales Value Proportion by Product in 2024
Table 91. Wuyao Pharmaceutical Sales Value Proportion by Application in 2024
Table 92. Wuyao Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 93. Wuyao Pharmaceutical Metronidazole SWOT Analysis
Table 94. Wuyao Pharmaceutical Recent Developments
Table 95. Yichang Changjiang Pharmaceutical Corporation Information
Table 96. Yichang Changjiang Pharmaceutical Description and Major Businesses
Table 97. Yichang Changjiang Pharmaceutical Product Models, Descriptions and Specifications
Table 98. Yichang Changjiang Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 99. Yichang Changjiang Pharmaceutical Recent Developments
Table 100. Tongji Pharmaceutical Corporation Information
Table 101. Tongji Pharmaceutical Description and Major Businesses
Table 102. Tongji Pharmaceutical Product Models, Descriptions and Specifications
Table 103. Tongji Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. Tongji Pharmaceutical Recent Developments
Table 105. Hongda Pharmaceutical Corporation Information
Table 106. Hongda Pharmaceutical Description and Major Businesses
Table 107. Hongda Pharmaceutical Product Models, Descriptions and Specifications
Table 108. Hongda Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 109. Hongda Pharmaceutical Recent Developments
Table 110. Topsun Pharmaceutical Corporation Information
Table 111. Topsun Pharmaceutical Description and Major Businesses
Table 112. Topsun Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Topsun Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 114. Topsun Pharmaceutical Recent Developments
Table 115. Unichem Laboratories Corporation Information
Table 116. Unichem Laboratories Description and Major Businesses
Table 117. Unichem Laboratories Product Models, Descriptions and Specifications
Table 118. Unichem Laboratories Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 119. Unichem Laboratories Recent Developments
Table 120. CordenPharma Farchemia Corporation Information
Table 121. CordenPharma Farchemia Description and Major Businesses
Table 122. CordenPharma Farchemia Product Models, Descriptions and Specifications
Table 123. CordenPharma Farchemia Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 124. CordenPharma Farchemia Recent Developments
Table 125. API Polpharma Corporation Information
Table 126. API Polpharma Description and Major Businesses
Table 127. API Polpharma Product Models, Descriptions and Specifications
Table 128. API Polpharma Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 129. API Polpharma Recent Developments
Table 130. Manav Drugs Corporation Information
Table 131. Manav Drugs Description and Major Businesses
Table 132. Manav Drugs Product Models, Descriptions and Specifications
Table 133. Manav Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 134. Manav Drugs Recent Developments
Table 135. Aarey Drugs & Pharmaceuticals Corporation Information
Table 136. Aarey Drugs & Pharmaceuticals Description and Major Businesses
Table 137. Aarey Drugs & Pharmaceuticals Product Models, Descriptions and Specifications
Table 138. Aarey Drugs & Pharmaceuticals Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 139. Aarey Drugs & Pharmaceuticals Recent Developments
Table 140. Aarti Drugs Corporation Information
Table 141. Aarti Drugs Description and Major Businesses
Table 142. Aarti Drugs Product Models, Descriptions and Specifications
Table 143. Aarti Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 144. Aarti Drugs Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Metronidazole Product Picture
Figure 2. Global Metronidazole Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Glyoxal Process Product Picture
Figure 4. Ethidene Diamine Process Product Picture
Figure 5. Others Product Picture
Figure 6. Global Metronidazole Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Metronidazole Tablets
Figure 8. Metronidazole Capsule
Figure 9. Metronidazole Injection
Figure 10. Others
Figure 11. Metronidazole Report Years Considered
Figure 12. Global Metronidazole Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 14. Global Metronidazole Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Metronidazole Revenue Market Share by Region (2020-2031)
Figure 16. Global Metronidazole Sales (2020-2031) & (MT)
Figure 17. Global Metronidazole Sales (CAGR) by Region (2020-2031) (MT)
Figure 18. Global Metronidazole Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Metronidazole Sales Volume Market Share in 2024
Figure 20. Global Metronidazole Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Glyoxal Process Revenue Market Share by Manufacturer in 2024
Figure 23. Ethidene Diamine Process Revenue Market Share by Manufacturer in 2024
Figure 24. Others Revenue Market Share by Manufacturer in 2024
Figure 25. Global Metronidazole Sales Market Share by Type (2020-2031)
Figure 26. Global Metronidazole Revenue Market Share by Type (2020-2031)
Figure 27. Global Metronidazole Sales Market Share by Application (2020-2031)
Figure 28. Global Metronidazole Revenue Market Share by Application (2020-2031)
Figure 29. North America Metronidazole Sales YoY (2020-2031) & (MT)
Figure 30. North America Metronidazole Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Metronidazole Sales Revenue (US$ Million) in 2024
Figure 32. North America Metronidazole Sales Volume (MT) by Type (2020- 2031)
Figure 33. North America Metronidazole Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Metronidazole Sales Volume (MT) by Application (2020-2031)
Figure 35. North America Metronidazole Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Metronidazole Sales YoY (2020-2031) & (MT)
Figure 40. Europe Metronidazole Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Metronidazole Sales Revenue (US$ Million) in 2024
Figure 42. Europe Metronidazole Sales Volume (MT) by Type (2020-2031)
Figure 43. Europe Metronidazole Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Metronidazole Sales Volume (MT) by Application (2020-2031)
Figure 45. Europe Metronidazole Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 47. France Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Metronidazole Sales YoY (2020-2031) & (MT)
Figure 52. Asia-Pacific Metronidazole Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Metronidazole Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Metronidazole Sales Volume (MT) by Type (2020- 2031)
Figure 55. Asia-Pacific Metronidazole Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Metronidazole Sales Volume (MT) by Application (2020-2031)
Figure 57. Asia-Pacific Metronidazole Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 62. India Metronidazole Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Metronidazole Sales YoY (2020-2031) & (MT)
Figure 64. Central and South America Metronidazole Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Metronidazole Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Metronidazole Sales Volume (MT) by Type (2021-2031)
Figure 67. Central and South America Metronidazole Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Metronidazole Sales Volume (MT) by Application (2020-2031)
Figure 69. Central and South America Metronidazole Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Metronidazole Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Metronidazole Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Metronidazole Sales YoY (2020-2031) & (MT)
Figure 73. Middle East and Africa Metronidazole Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Metronidazole Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Metronidazole Sales Volume (MT) by Type (2021-2031)
Figure 76. South America Metronidazole Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Metronidazole Sales Volume (MT) by Application (2020-2031)
Figure 78. Middle East and Africa Metronidazole Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Metronidazole Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Metronidazole Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Metronidazole Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Metronidazole Revenue (2020-2025) & (US$ Million)
Figure 83. Metronidazole Industry Chain Mapping
Figure 84. Regional Metronidazole Manufacturing Base Distribution (%)
Figure 85. Global Metronidazole Production Market Share by Region (2020-2031)
Figure 86. Metronidazole Production Process
Figure 87. Regional Metronidazole Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Metronidazole in 2025?
The global market size of Metronidazole in 2025 was 111 Million USD.
What was the global market size of Metronidazole in 2031?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Metronidazole market size from 2025 to 2031?
Which companies rank high in the global Metronidazole market?
Related Reports
Global Metronidazole Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
Global Metronidazole Market Research Report 2026
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 123
USD 2900.00
(Single User License)
Metronidazole- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
Global Metronidazole Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 154
USD 5900.00
(Single User License)
Global Metronidazole Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
Metronidazole- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
Global Metronidazole Market Research Report 2025
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
Global Metronidazole Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-17
Pages: 179
USD 5600.00
(Single User License)
Global Metronidazole Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-16
Pages: 170
USD 5900.00
(Single User License)
Global Metronidazole Market Insights, Forecast to 2030
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
Global Metronidazole Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
USD 4250.00 (Single User License)Global Metronidazole Market Research Report 2026
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 123
USD 2900.00 (Single User License)Metronidazole- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
USD 3950.00 (Single User License)Global Metronidazole Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 154
USD 5900.00 (Single User License)Global Metronidazole Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
USD 4250.00 (Single User License)Metronidazole- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
USD 3950.00 (Single User License)Global Metronidazole Market Research Report 2025
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published: 2025-01-16
Pages: 95
USD 2900.00 (Single User License)Global Metronidazole Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-17
Pages: 179
USD 5600.00 (Single User License)Global Metronidazole Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-16
Pages: 170
USD 5900.00 (Single User License)Global Metronidazole Market Insights, Forecast to 2030
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-07
Pages: 115
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now